FundedIQ
Biotechnology

SQZ Biotech: Funding, Investors & Team (Sep 2026)

SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.

sqzbiotech.com LinkedIn Watertown, United States 101-250 employees
Biotechnology Life Science Therapeutics
Total raised
$2.0M
Rounds
1
Latest
Grant
Mar 2022

SQZ Biotech has raised $2.0M across 1 funding round on record, the most recent a Grant of $2.0M announced in Mar 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

SQZ Biotech Company Profile and Key Stats

Total funding raised
$2.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Grant
$2.0M in Mar 2022
Employees
101-250
reported band
Headquarters
Watertown, United States

Latest funding round on record: Mar 2022.

SQZ Biotech Funding Rounds

Date
Round
Amount
Grant
$2.0M

SQZ Biotech Founders and Leadership Team

Name
Role
Contact
Armon Sharei
CEO
Locked

Contact details for the SQZ Biotech team: 1 of 1 has an email address on file.

Start 14-day free trial →

SQZ Biotech Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
1,065

SQZ Biotech's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like SQZ Biotech in Biotechnology and Watertown

Companies Similar to SQZ Biotech

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

SQZ Biotech Funding FAQs

What does SQZ Biotech do?

SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.

How much funding has SQZ Biotech raised?

SQZ Biotech has raised $2.0M across 1 round on record. The most recent is a Grant of $2.0M announced in Mar 2022.

When did SQZ Biotech last raise funding?

SQZ Biotech's most recent funding round on record is a Grant of $2.0M, announced in Mar 2022.

Who is the CEO of SQZ Biotech?

Armon Sharei is listed as CEO at SQZ Biotech.

Where is SQZ Biotech headquartered?

SQZ Biotech is based in Watertown, Massachusetts, United States.

How many employees does SQZ Biotech have?

SQZ Biotech is in the 101-250 employee band.

How does SQZ Biotech's funding compare to other Biotechnology startups?

SQZ Biotech's latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's SQZ Biotech Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SQZ Biotech is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.